<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982385</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5309</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065309</ELocationID><Abstract><AbstractText>The coxsackievirus and adenovirus receptor (CAR) is very well known as an epithelial tight junction and cardiac intercalated disc protein; it mediates attachment and infection via the coxsackievirus B3 (CVB3) and type 5 adenovirus. Macrophages play important roles in early immunity during viral infections. However, the role of CAR in macrophages is not well studied in relation to CVB3 infection. In this study, the function of CAR was observed in the Raw264.7 mouse macrophage cell line. CAR expression was stimulated by treatment with lipopolysaccharide (LPS) and tumor necrosis factor-α (TNF-α). In thioglycollate-induced peritonitis, the peritoneal macrophage was activated and CAR expression was increased. The macrophage-specific CAR conditional knockout mice (KO) were generated from lysozyme Cre mice. The expression of inflammatory cytokine (IL-1β and TNF-α) was attenuated in the KO mice's peritoneal macrophage after LPS treatment. In addition, the virus was not replicated in CAR-deleted macrophages. The organ virus replication was not significantly different in both wild-type (WT) and KO mice at days three and seven post-infection (p.i). However, the inflammatory M1 polarity genes (IL-1β, IL-6, TNF-α and MCP-1) were significantly increased, with increased rates of myocarditis in the heart of KO mice compared to those of WT mice. In contrast, type1 interferon (IFN-α and β) was significantly decreased in the heart of KO mice. Serum chemokine CXCL-11 was increased in the KO mice at day three p.i. compared to the WT mice. The attenuation of IFN-α and β in macrophage CAR deletion induced higher levels of CXCL-11 and more increased CD4 and CD8 T cells in KO mice hearts compared to those of WT mice at day seven p.i. These results demonstrate that macrophage-specific CAR deletion increased the macrophage M1 polarity and myocarditis in CVB3 infection. In addition, chemokine CXCL-11 expression was increased, and stimulated CD4 and CD8 T cell activity. Macrophage CAR may be important for the regulation of innate-immunity-induced local inflammation in CVB3 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ha-Hyeon</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Eun-Seok</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon Dong, Gangnam-gu, Seoul 06351, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Byung-Kwan</ForeName><Initials>BK</Initials><Identifier Source="ORCID">0000-0003-3974-1175</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Science, Jungwon University, Goesan-gun 28024, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NRF-2019R1F1A1057678</GrantID><Agency>National Research Foundation of Korea</Agency><Country /></Grant><Grant><GrantID>HV22C0160</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C085301">adenovirus receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coxsackievirus B3</Keyword><Keyword MajorTopicYN="N">coxsackievirus and adenovirus receptor</Keyword><Keyword MajorTopicYN="N">macrophage polarity</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982385</ArticleId><ArticleId IdType="pmc">PMC10049483</ArticleId><ArticleId IdType="doi">10.3390/ijms24065309</ArticleId><ArticleId IdType="pii">ijms24065309</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lim B.K., Xiong D., Dorner A., Youn T.J., Yung A., Liu T.I., Gu Y., Dalton N.D., Wright A.T., Evans S.M., et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J. Clin. Investig. 2008;118:2758–2770. doi: 10.1172/JCI34777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34777</ArticleId><ArticleId IdType="pmc">PMC2467382</ArticleId><ArticleId IdType="pubmed">18636119</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne C.B., Bergelson J.M. CAR: A virus receptor within the tight junction. Adv. Drug Deliv. Rev. 2005;57:869–882. doi: 10.1016/j.addr.2005.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2005.01.007</ArticleId><ArticleId IdType="pubmed">15820557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.W., Zhou B., Yu Q.C., Shin S.J., Jiao K., Schneider M.D., Baldwin H.S., Bergelson J.M. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ. Res. 2006;98:923–930. doi: 10.1161/01.RES.0000218041.41932.e3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000218041.41932.e3</ArticleId><ArticleId IdType="pubmed">16543498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen C.J., Shieh J.T., Pickles R.J., Okegawa T., Hsieh J.T., Bergelson J.M. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc. Natl. Acad. Sci. USA. 2001;98:15191–15196. doi: 10.1073/pnas.261452898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.261452898</ArticleId><ArticleId IdType="pmc">PMC65005</ArticleId><ArticleId IdType="pubmed">11734628</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher D.R., Cerny A.M., Weiler S.R., Horner J.W., Keeler M.L., Neptune M.A., Jones S.N., Bronson R.T., Depinho R.A., Finberg R.W. Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis. 2005;42:77–85. doi: 10.1002/gene.20127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.20127</ArticleId><ArticleId IdType="pubmed">15864812</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorner A.A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., Nasdala I., August B., Westermann J., Rathjen F.G., et al. Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development. Pt 15J. Cell Sci. 2005;118:3509–3521. doi: 10.1242/jcs.02476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.02476</ArticleId><ArticleId IdType="pubmed">16079292</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J.H., Shin H.H., Rhyu H.S., Kim S.H., Jeon E.S., Lim B.K. Vascular Endothelial Integrity Affects the Severity of Enterovirus-Mediated Cardiomyopathy. Int. J. Mol. Sci. 2021;22:3053. doi: 10.3390/ijms22063053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22063053</ArticleId><ArticleId IdType="pmc">PMC8002520</ArticleId><ArticleId IdType="pubmed">33802680</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J., Kim K.H., An S.H., Lee S., Lim B.K., Kang S.W., Kwon K. Coxsackievirus and adenovirus receptor mediates the responses of endothelial cells to fluid shear stress. Exp. Mol. Med. 2019;51:1–15. doi: 10.1038/s12276-019-0347-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0347-7</ArticleId><ArticleId IdType="pmc">PMC6881322</ArticleId><ArticleId IdType="pubmed">31776326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.K., Choi J.H., Nam J.H., Gil C.O., Shin J.O., Yun S.H., Kim D.K., Jeon E.S. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc. Res. 2006;71:517–526. doi: 10.1016/j.cardiores.2006.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.05.016</ArticleId><ArticleId IdType="pubmed">16806133</ArticleId></ArticleIdList></Reference><Reference><Citation>Baboonian C., Davies M.J., Booth J.C., McKenna W.J. Current Topics in Microbiology and Immunology. Volume 223. Springer; Berlin/Heidelberg, Germany: 1997. Coxsackie B viruses and human heart disease; pp. 31–52.</Citation><ArticleIdList><ArticleId IdType="pubmed">9294924</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S.A., Lodge P.A. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 1986;122:284–291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1888112</ArticleId><ArticleId IdType="pubmed">3004227</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff J.F. Viral myocarditis. A review. Am. J. Pathol. 1980;101:425–484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1903609</ArticleId><ArticleId IdType="pubmed">6254364</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton K.U., Badorff C. The immune system in viral myocarditis: Maintaining the balance. Circ. Res. 1999;85:559–561. doi: 10.1161/01.RES.85.6.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.85.6.559</ArticleId><ArticleId IdType="pubmed">10488059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.M., Lim B.K., Ho S.H., Yun S.H., Shin J.O., Park E.M., Kim D.K., Kim S., Jeon E.S. TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis. Biochem. Biophys. Res. Commun. 2006;344:765–771. doi: 10.1016/j.bbrc.2006.03.170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.03.170</ArticleId><ArticleId IdType="pubmed">16631119</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.K., Choe S.C., Shin J.O., Ho S.H., Kim J.M., Yu S.S., Kim S., Jeon E.S. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation. 2002;105:1278–1281. doi: 10.1161/circ.105.11.1278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.105.11.1278</ArticleId><ArticleId IdType="pubmed">11901035</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Yue Y., Xiong S. NK-derived IFN-gamma/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis. J. Mol. Cell. Cardiol. 2014;76:15–25. doi: 10.1016/j.yjmcc.2014.07.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2014.07.021</ArticleId><ArticleId IdType="pubmed">25123338</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino T.A., Liu P., Sole M.J. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 1994;74:182–188. doi: 10.1161/01.RES.74.2.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.74.2.182</ArticleId><ArticleId IdType="pubmed">8293557</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Martino T., Opavsky M.A., Penninger J. Viral myocarditis: Balance between viral infection and immune response. Can. J. Cardiol. 1996;12:935–943.</Citation><ArticleIdList><ArticleId IdType="pubmed">9191484</ArticleId></ArticleIdList></Reference><Reference><Citation>Alidjinou E.K., Sane F., Trauet J., Copin M.C., Hober D. Coxsackievirus B4 Can Infect Human Peripheral Blood-Derived Macrophages. Viruses. 2015;7:6067–6079. doi: 10.3390/v7112924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7112924</ArticleId><ArticleId IdType="pmc">PMC4664995</ArticleId><ArticleId IdType="pubmed">26610550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitina E., Larionova I., Choinzonov E., Kzhyshkowska J. Monocytes and Macrophages as Viral Targets and Reservoirs. Int. J. Mol. Sci. 2018;19:2821. doi: 10.3390/ijms19092821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19092821</ArticleId><ArticleId IdType="pmc">PMC6163364</ArticleId><ArticleId IdType="pubmed">30231586</ArticleId></ArticleIdList></Reference><Reference><Citation>Matveeva O., Nechipurenko Y., Lagutkin D., Yegorov Y.E., Kzhyshkowska J. SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: Antibody-dependent as well as independent cell entry. Front. Immunol. 2022;13:1050478. doi: 10.3389/fimmu.2022.1050478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1050478</ArticleId><ArticleId IdType="pmc">PMC9751203</ArticleId><ArticleId IdType="pubmed">36532011</ArticleId></ArticleIdList></Reference><Reference><Citation>Famulski K.S., Kayser D., Einecke G., Allanach K., Badr D., Venner J., Sis B., Halloran P.F. Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts. Am. J. Transplant. 2010;10:490–497. doi: 10.1111/j.1600-6143.2009.02983.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2009.02983.x</ArticleId><ArticleId IdType="pubmed">20121742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica A., Mantovani A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Investig. 2016;122:787–795. doi: 10.1172/JCI59643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59643</ArticleId><ArticleId IdType="pmc">PMC3287223</ArticleId><ArticleId IdType="pubmed">22378047</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith T.D., Tse M.J., Read E.L., Liu W.F. Regulation of macrophage polarization and plasticity by complex activation signals. Integr. Biol. 2016;8:946–955. doi: 10.1039/c6ib00105j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6ib00105j</ArticleId><ArticleId IdType="pmc">PMC5148158</ArticleId><ArticleId IdType="pubmed">27492191</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayagaki N., Wong M.T., Stowe I.B., Ramani S.R., Gonzalez L.C., Akashi-Takamura S., Miyake K., Zhang J., Lee W.P., Muszynski A., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341:1246–1249. doi: 10.1126/science.1240248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1240248</ArticleId><ArticleId IdType="pubmed">23887873</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep. 2014;6:13. doi: 10.12703/P6-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/P6-13</ArticleId><ArticleId IdType="pmc">PMC3944738</ArticleId><ArticleId IdType="pubmed">24669294</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S., Ge H., Li S., Qiu H.J. Modulation of Macrophage Polarization by Viruses: Turning Off/On Host Antiviral Responses. Front. Microbiol. 2022;13:839585. doi: 10.3389/fmicb.2022.839585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.839585</ArticleId><ArticleId IdType="pmc">PMC8874017</ArticleId><ArticleId IdType="pubmed">35222345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Wang S., Chen X., Cheng S., Zhang Z., Li F., Huang L., Yang Y., Zhou B., Yue D., et al. Cancer-cell-secreted CXCL11 promoted CD8(+) T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J. Immunother. Cancer. 2019;7:42. doi: 10.1186/s40425-019-0511-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40425-019-0511-6</ArticleId><ArticleId IdType="pmc">PMC6371476</ArticleId><ArticleId IdType="pubmed">30744691</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S.H., Lee W.G., Kim Y.C., Ju E.S., Lim B.K., Choi J.O., Kim D.K., Jeon E.S. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. J. Infect. Dis. 2012;205:491–497. doi: 10.1093/infdis/jir745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jir745</ArticleId><ArticleId IdType="pubmed">22207647</ArticleId></ArticleIdList></Reference><Reference><Citation>Babaev V.R., Yancey P.G., Ryzhov S.V., Kon V., Breyer M.D., Magnuson M.A., Fazio S., Linton M.F. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2005;25:1647–1653. doi: 10.1161/01.ATV.0000173413.31789.1a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000173413.31789.1a</ArticleId><ArticleId IdType="pubmed">15947238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Shin H.H., Kim J.H., Park J.H., Jeon E.S., Lim B.K. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis. Int. J. Mol. Sci. 2022;23:1489. doi: 10.3390/ijms23031489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031489</ArticleId><ArticleId IdType="pmc">PMC8836114</ArticleId><ArticleId IdType="pubmed">35163412</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>